Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria. Read more about Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura. Read more about A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
A randomized trial of blood donor recruitment strategies. Read more about A randomized trial of blood donor recruitment strategies.
Factors influencing the decision to donate: racial and ethnic comparisons. Read more about Factors influencing the decision to donate: racial and ethnic comparisons.
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Read more about Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
The impact of male-to-male sexual experience on risk profiles of blood donors. Read more about The impact of male-to-male sexual experience on risk profiles of blood donors.
Minimum conditions of major histocompatibility complex compatibility and recipient immune compromise required to establish donor white blood cell persistence in a murine transfusion model. Read more about Minimum conditions of major histocompatibility complex compatibility and recipient immune compromise required to establish donor white blood cell persistence in a murine transfusion model.
Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Read more about Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Read more about Quantifying losses to the donated blood supply due to donor deferral and miscollection.
Estimating blood donor loss due to the variant CJD travel deferral. Read more about Estimating blood donor loss due to the variant CJD travel deferral.
